Kumar · Handbook of experimental pharmacology 2022 · narrative review · n=?

Toll-Like Receptors in Adaptive Immunity.

Cited 44 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review/book chapter describing biological mechanisms with no primary human data.

PubMed 34510306 · doi:10.1007/164_2021_543 · record verified 2026-08-26

What was done

This book chapter reviews the evolutionary history, signaling pathways, and biological functions of Toll-like receptors (TLRs). It synthesizes existing knowledge regarding the expression and functional roles of human (TLR1–10) and murine (TLR1–13) receptors across innate immune cells and adaptive lymphocyte populations, including B cells, CD4+ T cells, CD8+ T cells, and regulatory T cells.

What was found

The abstract reports no empirical data or quantitative effect estimates. It notes qualitative characterizations: humans express 10 functional TLRs (TLR1–TLR10), whereas mice have 12 (TLR1–TLR13, with TLR10 existing only as a non-functional pseudogene), and confirms that TLRs act directly on adaptive immune cell subsets.

Why it matters

Recognizing that TLR signaling directly regulates lymphocyte activity expands understanding of immune crosstalk and informs the development of TLR-targeted adjuvants and immunotherapies for infections, autoimmune disorders, and cancers.

Limits

This work is a narrative review chapter that presents no original clinical trials, observational cohorts, or primary quantitative datasets in the abstract. Methodological review criteria and synthesis protocols are not described.

Cited by